Award
Delivery Order #SPE2DR26FMJU3
Short-Term Delivery Order for Midazolam Hydrochloride to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$8.50
Ceiling
$8.50
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26FMJU3
NAICS
424210
This award is a delivery order contract under an existing indefinite delivery vehicle (IDV) previously granted to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical services. The contract involves procuring Midazolam Hydrochloride, a critical pharmaceutical product used in medical treatments. This short-term contract covers a specific and immediate supply need, with a performance window lasting only a few days in early March 2026. The order contributes to the agency's ongoing pharmaceutical supply chain management by ensuring timely availability of essential medicines. As a delivery order under a competitively awarded IDV, it leverages the established framework to expedite procurement efficiently. The contract emphasizes continuity in pharmaceutical service support and supports the government's healthcare operational readiness.
Description
4571140589! MIDAZOLAM HYDROCHLORI